Bio-Path Holdings, Inc. (NASDAQ:BPTH – Get Free Report) was the recipient of a significant drop in short interest during the month of October. As of October 31st, there was short interest totalling 77,800 shares, a drop of 80.0% from the October 15th total of 388,600 shares. Currently, 2.1% of the shares of the stock are short sold. Based on an average daily trading volume, of 1,410,000 shares, the short-interest ratio is presently 0.1 days.
Wall Street Analyst Weigh In
Separately, StockNews.com initiated coverage on shares of Bio-Path in a report on Friday. They issued a “sell” rating on the stock.
Hedge Funds Weigh In On Bio-Path
Bio-Path Trading Down 3.2 %
Shares of NASDAQ BPTH traded down $0.03 on Tuesday, reaching $0.87. 30,121 shares of the company traded hands, compared to its average volume of 1,154,581. The company has a 50 day moving average of $0.99 and a 200 day moving average of $1.63. Bio-Path has a fifty-two week low of $0.80 and a fifty-two week high of $12.40.
Bio-Path (NASDAQ:BPTH – Get Free Report) last issued its quarterly earnings results on Thursday, August 15th. The company reported ($1.16) EPS for the quarter, beating analysts’ consensus estimates of ($1.54) by $0.38. During the same period last year, the business earned ($10.60) EPS. As a group, equities analysts predict that Bio-Path will post -6.2 earnings per share for the current year.
About Bio-Path
Bio-Path Holdings, Inc operates as a clinical and preclinical stage oncology focused RNAi nanoparticle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology platform that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the DNA from destruction.
Featured Articles
- Five stocks we like better than Bio-Path
- ETF Screener: Uses and Step-by-Step Guide
- Home Depot Stock: Targeting 12% in 2024 and 25% More in 2025
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Is Tesla’s Valuation a Bubble or Backed by Real Growth?
- What Investors Need to Know to Beat the Market
- Trucking Stocks Led the Pack Last Week: Can They Keep Rolling?
Receive News & Ratings for Bio-Path Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bio-Path and related companies with MarketBeat.com's FREE daily email newsletter.